tetano
Editor, Senior Moderator
Ocul Immunol Inflamm
. 2023 Feb 17;1-3.
doi: 10.1080/09273948.2023.2176887. Online ahead of print.
Retinal Vasculitis Following COVID-19 Vaccination: Causation or Coincidence?
Zuohuizi Yi[SUP] 1 [/SUP], Liao Chen[SUP] 2 [/SUP], Hongmei Zheng[SUP] 1 [/SUP], Changzheng Chen[SUP] 1 [/SUP]
Affiliations
Abstract
Background: With the popularity of coronavirus disease 2019 (COVID-19) vaccination, some rare ocular adverse events have gradually been reported. This report shows a rare case of retinal vasculitis following COVID-19 vaccination.
Description: A 37-year-old male complained of unilateral severe vision loss 13 days after the first dose of an inactivated COVID-19 vaccine. The initial eye examination showed gray-white edema in the macula, and scattered patchy gray-white lesions in the peripheral retina, accompanied by peripheral retinal small vessel occlusion. After glucocorticoid treatment, the gray-white lesions gradually subsided. However, due to the initial severe damage in the fundus, macular and peripheral retinal lesions were significantly atrophied, and the vision recovery was poor.
Conclusion: The ocular adverse event in this report may be related to the inactivated COVID-19 vaccination, however, it is difficult to rule out the accidental rare adverse events after a large number of vaccinations.
Keywords: COVID-19; retinal vasculitis; vaccination; vaccine; vision loss.
. 2023 Feb 17;1-3.
doi: 10.1080/09273948.2023.2176887. Online ahead of print.
Retinal Vasculitis Following COVID-19 Vaccination: Causation or Coincidence?
Zuohuizi Yi[SUP] 1 [/SUP], Liao Chen[SUP] 2 [/SUP], Hongmei Zheng[SUP] 1 [/SUP], Changzheng Chen[SUP] 1 [/SUP]
Affiliations
- PMID: 36799876
- DOI: 10.1080/09273948.2023.2176887
Abstract
Background: With the popularity of coronavirus disease 2019 (COVID-19) vaccination, some rare ocular adverse events have gradually been reported. This report shows a rare case of retinal vasculitis following COVID-19 vaccination.
Description: A 37-year-old male complained of unilateral severe vision loss 13 days after the first dose of an inactivated COVID-19 vaccine. The initial eye examination showed gray-white edema in the macula, and scattered patchy gray-white lesions in the peripheral retina, accompanied by peripheral retinal small vessel occlusion. After glucocorticoid treatment, the gray-white lesions gradually subsided. However, due to the initial severe damage in the fundus, macular and peripheral retinal lesions were significantly atrophied, and the vision recovery was poor.
Conclusion: The ocular adverse event in this report may be related to the inactivated COVID-19 vaccination, however, it is difficult to rule out the accidental rare adverse events after a large number of vaccinations.
Keywords: COVID-19; retinal vasculitis; vaccination; vaccine; vision loss.